NASDAQ:CBLI - Cleveland BioLabs, Inc.
$1.51
 $0.03
+2.03%
4:00PM EDT
2019-04-18
Cleveland BioLabs, Inc. (CBLI), incorporated on June 5, 2003, is a biopharmaceutical company. The Company is engaged in developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. CBLI's advanced product candidate is Entolimod, an immuno-stimulatory agent, which the Company is developing as a radiation countermeasure and an immunotherapy for oncology and other indications. The Company's other products include CBLB612, Mobilan and CBL0137. Entolimod is a Toll-like receptor 5 (TLR5), agonist, which the Company is developing as a radiation countermeasure for prevention of death from acute radiation syndrome (ARS) and as an oncology drug. Entolimod is being developed for the indication of reducing the risk of death following exposure to potentially lethal irradiation occurring as a result of a radiation disaster. It has completed clinical studies designed to evaluate the safety, pharmacokinetics and pharmacodynamics. It has completed a Good Laboratory Practices (GLP), randomized, blinded, placebo-controlled, pivotal study designed to evaluate the dose-dependent effect of Entolimod on survival and biomarker induction.CBLB612 is a compound based upon a natural activator of another tissue-specific component of the innate immune system, the toll-like receptor 2 (TLR2)/ toll-like receptor 6 (TLR6) heterodimeric receptor. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  CBLI     avg for
industry  
  avg for
sector  
42 stocks weight:  0. 19   203. 85   241. 91  
42 stocks rank:  4. 16 K 1. 44 K 1. 05 K
# analyst opinions:  1. 00   14. 51   13. 97  

quick ratio:  4. 79   5. 27   1. 81  
current ratio:  4. 91   5. 62   2. 25  

target price low:  2. 00   84. 80   115. 21  
target price avg:  2. 00   111. 51   137. 51  
target price high:  2. 00   135. 81   157. 84  
1-yr high:  2. 92   114. 23   138. 78  
last close:  1. 51   87. 66   116. 69  
50-day avg:  1. 55   95. 54   123. 44  
200-day avg:  1. 77   94. 25   121. 11  
1-yr low:  1. 01   72. 78   98. 34  
volume:  2. 01 K 4. 11 M 8. 07 M
50-day avg volume:  11. 33 K 2. 76 M 5. 02 M
200-day avg volume:  11. 90 K 2. 92 M 4. 59 M

1-day return:  2. 03 % -0. 41 % 0. 07 %
this week return:  -6. 79 % -5. 74 % -4. 11 %
12-wk return:  2. 72 % 1. 61 % -0. 05 %
52-wk return:  -48. 79 % 3. 12 % 8. 78 %

enterprise value (EV):  18. 02 M 48. 94 B 114. 64 B
market cap:  17. 06 M 43. 07 B 104. 73 B
EBITDA:  -4. 78 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -3. 77   4. 22   12. 73  
enterprise/revenue (EV/R):  15. 84   63. 17   12. 84  
total revenue:  1. 14 M 10. 62 B 38. 47 B
total debt:  0. 00   12. 24 B 16. 73 B
net income (common):  -3. 61 M 2. 20 B 4. 20 B

shares outstanding:  11. 30 M 571. 70 M 1. 24 B
shares:  4. 73 M 571. 81 M 1. 23 B
shares short:  21. 24 K 10. 17 M 13. 00 M
shares short prior month:  20. 92 K 9. 54 M 17. 33 M
short ratio:  1. 18   5. 41   3. 28  
short % of float:  0. 45 % 5. 45 % 2. 38 %
total cash/share:  0. 36   11. 14   9. 33  
total cash:  4. 12 M 6. 71 B 7. 15 B
free cash flow:  -3. 88 M 3. 58 B 2. 96 B
operating cash flow:  -4. 61 M 4. 15 B 4. 30 B

book value:  -0. 13   12. 78   26. 92  
price/book:  -11. 71   3. 06   -1. 74  
gross profits:  -2. 48 M 8. 04 B 34. 86 B
operating margins:  -421. 71 % -725. 35 % -89. 04 %
EBITDA margins:  0. 00 % 10. 94 % 22. 51 %
profit margins:  0. 00 % 7. 81 % 10. 57 %
gross margins:  -217. 97 % 37. 08 % 55. 70 %

1-yr max volatility:  60. 63 % --- ---
1-yr mean volatility:  -0. 09 % 0. 03 % 0. 04 %

1-yr EPS:  -0. 32   2. 40   4. 10  
P/E:  -4. 72   13. 63   22. 72  
PE/G:  0. 06   -1. 65   -1. 32  
growth:  -72. 90 % 127. 12 % 29. 61 %
earnings high:  -0. 00   1. 00   1. 66  
earnings avg:  -0. 00   0. 77   1. 53  
earnings low:  -0. 00   0. 50   1. 39  
revenue high:  -0. 00   2. 68 B 10. 78 B
revenue avg:  -0. 00   2. 59 B 10. 57 B
revenue low:  -0. 00   2. 49 B 10. 36 B
return on assets:  -42. 36 % -2. 75 % 4. 55 %
return on equity:  -67. 27 % -18. 45 % 5. 46 %
revenue growth:  -72. 90 % 92. 86 % 18. 96 %
revenue/share:  0. 10   13. 29   55. 46  

beta (1yr vs S&P500):  0. 25   1. 25   0. 93  
sharpe (1yr):  -0. 24   0. 37   0. 70  

held % insiders:  58. 14 % 6. 39 % 3. 38 %
held % institutions:  5. 41 % 78. 14 % 68. 52 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-21 : CBLI
.    + 0.909 =         0.909 :: INITIAL WEIGHT
.   + 43.239 =        44.148 :: spline projection addition
.    x 1.431 =        63.194 :: industry recommendation factor
.    x 1.251 =        79.035 :: EV/R factor
.    x 0.996 =          78.7 :: return on assets factor
.    x 0.993 =        78.171 :: return on equity factor
.    x 0.993 =        77.601 :: revenue growth factor
.    x 2.873 =       222.934 :: current ratio factor
.    x 1.124 =       250.591 :: quick ratio factor
.    x 1.359 =       340.606 :: short ratio factor
.    x 1.883 =       641.343 :: price-to-book factor
.      x 1.0 =       641.591 :: 5-day avg > 50-day avg
.    x 2.092 =      1342.525 :: P/E weight
.    x 1.983 =      2661.629 :: PE/G factor
.    x 1.334 =       3551.08 :: beta factor
.    x 0.245 =       868.359 :: sharpe factor
.    x 1.599 =      1388.523 :: target low factor
.     x 1.19 =      1652.181 :: target mean factor
.    x 1.057 =      1746.298 :: target high factor
.     x 1.31 =      2287.455 :: industry 2-weeks return factor
.    x 0.927 =        2120.9 :: "drift" penalty 3 days ago
.    x 0.926 =      1963.375 :: "drift" penalty 4 days ago
.    x 0.811 =      1591.927 :: overall "drift" factor
.    x 0.394 =       626.743 :: largest single-day jump factor
.    x 0.064 =        39.996 :: low price factor
.      x 1.0 =         39.99 :: factor hist industry gain for week 16
.   cubeRoot =          3.42 :: reduced to standardize
.   - 25.476 =         0.195 :: add/subtract for performance
.                      0.195 :: FINAL WEIGHT for NASDAQ:CBLI


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org